News articles

News article list

• NICE publishes first quality standard to improve care for people with rare diseases

  Ahead of Rare Disease Day on 28 February, we've published our first ever quality standard on rare diseases, and the first to have been developed in partnership with an external organisation.

• More than 20,000 people benefitting from innovative migraine pills recommended by NICE

  A new type of tablet specifically designed to prevent migraine is transforming lives across England, with the number of people being prescribed these medicines more than tripling in just one year.

• First treatment for vitiligo recommended by NICE for NHS use, bringing hope to over 80,000 people

  For the first time, NICE has recommended a medicine that effectively treats the underlying cause of devastating skin condition vitiligo

• Major changes to type 2 diabetes treatment could save thousands of lives

  New guidance means millions of people will get access to medicines that protect the heart and kidneys, while NHS savings of £560 million from using generic dapagliflozin can be reinvested elsewhere in NHS care.

• NICE recommends first ever disease modifying treatment for ultra-rare metabolic condition ARG1 deficiency

  Nice has recommended the first disease modifying treatment for arginase 1 deficiency (ARG1-D), an ultra-rare, inherited and progressive metabolic disorder, for routine use in the NHS in England.